Cue Biopharma (CUE) logo

Cue Biopharma (CUE) stock

Worth $34.7MShares as of Nov 13

$4.15
-7.78%

Not scored

Breakaway doesn't score CUE. It is too small for a fair Quality Score.

Healthcare · Biotech

NextEnd of 2026“…by the end of this quarter and remain on track to initiate a CUE-401 Phase 1 study by the end of the year…”Trial start · SEC filing · Aug 14
Cash$57.9M, about 4 quarters at the last year's spendingOn Sep 30

Follow CUE's news. Pro members can get an alert when Cue Biopharma files news, and see its trials, share raises, and its CEO's filings.

Get an alert when CUE files newsSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. 3,170 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$57.9M, about 4 quarters at the last year's spendingOn Sep 30

What's next for CUE, and how long its cash lasts

Next step the company has named

End of 2026“We look forward to anticipated CUE-221 Phase 2 data by the end of this quarter and remain on track to initiate a CUE-401 Phase 1 study by the end of the year.”Trial start · SEC filing · Aug 14

What it means: when a trial begins, or reaches the stage the company named.

Lead program
CUE-221

For Pro members: 39 filings.

Cash runway Sep 30 balance sheet

About 4 quarters

$57.9M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3, filed Mar 16, 2026)
  • At-the-market share sales program (S-3, filed Mar 16, 2026)

For Pro members: 3 raises and their amounts, and the share count against a year ago.

Insiders

An officer, Michael Vincent Meluzio, sold 1,144 shares on Oct 12. 5 more insider trades this year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Shao-Lee Lin’s 13 filings and quotes.

Get an alert when CUE files newsA free account. No card.Pro: $1 first month.Pro, 7 days free with a card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

12 more FDA dates and 98 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 144 dates, ranked →See all 144 dates, ranked →Start Pro

CUE's latest filings

41 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why CUE isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. CUE is worth about $34.7M. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See every stock rankedSee every stock rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.